DEXTRAN 75 injection, powder, lyophilized, for solution

Pajjiż: Stati Uniti

Lingwa: Ingliż

Sors: NLM (National Library of Medicine)

Ingredjent attiv:

DEXTRAN 75 (UNII: JY83SHX053) (DEXTRAN 75 - UNII:JY83SHX053)

Disponibbli minn:

AnazaoHealth Corporation

INN (Isem Internazzjonali):

DEXTRAN 75

Kompożizzjoni:

DEXTRAN 75 10 mg

Rotta amministrattiva:

INTRAVENOUS

Tip ta 'preskrizzjoni:

PRESCRIPTION DRUG

Indikazzjonijiet terapewtiċi:

Technetium Tc99m Dextran by intravenous administration is indicated as a cardiac blood pool imaging agent and as an adjunct in the diagnosis of pericardial effusion, ventricular aneurysm, or GI Bleed

L-istatus ta 'awtorizzazzjoni:

unapproved drug other

Karatteristiċi tal-prodott

DEXTRAN 75 - DEXTRAN 75 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
ANAZAOHEALTH CORPORATION
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
DEXTRAN 75
Dear Medical Professional,
Per your order, we have compounded Dextran 75 as a lyophilized powder
for injection. The
characteristics of this preparation are as follows:
DESCRIPTION
AnazaoHealth supplies compounded Dextran 75 for the preparation of
Tc-99m Dextran 75. Each
reaction vial contains 10 mg of Dextran 75, 0.30mg of stannous
chloride, 0.73 mg Sodium Citrate and 1
mg of dextrose (lyophilized mixture, under nitrogen atmosphere), per
unit dose vial.
MECHANISM OF ACTION
Dextran, when labeled with technetium Tc99m and given intravenously,
is distributed throughout the
body in much the same way as the patient’s serum, and serves as a
suitable tracer with which to
transiently image the vascular compartment
INDICATIONS AND USAGE
Technetium Tc99m Dextran by intravenous administration is indicated as
a cardiac blood pool imaging
agent and as an adjunct in the diagnosis of pericardial effusion,
ventricular aneurysm, or GI Bleed
DOSAGE AND ADMINISTRATION
To prepare injection, up to 40 mCi of an oxidant-free sodium
pertechnetate Tc 99m solution is
aseptically injected into the vial, minimum volume 1ml, mix gently and
let Dextran dissolve completely
for 10 minutes
STORAGE AND HANDLING
Injection should be administered within 6 hours after preparation.
Before and after reconstitution- Store
at room temperature
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FIGURE 1
AnazaoHealth Corporation
DEXTRAN 75
dextran 75 injection, powder, lyophilized, for solution
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:518 0 8 -210
ROUTE OF ADMINISTRATION
INTRAVENOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
DEXTRAN 7 5 (UNII: JY8 3SHX0 53) (DEXTRAN 75 - UNII:JY8 3SHX0 53)
DEXTRAN